Overview

Multicenter Unsustained Tachycardia Trial (MUSTT)

Status:
Completed
Trial end date:
1996-09-01
Target enrollment:
0
Participant gender:
All
Summary
To determine the value of electrophysiologic (EP)-guided antiarrhythmic therapy in coronary heart disease patients at increased risk for sudden death. The study included a controlled clinical trial and a registry.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Anti-Arrhythmia Agents
Criteria
Men and women patients with documented coronary artery disease, ejection fraction less than
or equal to 40 percent, and nonsustained asymptomatic ventricular tachycardia.